PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1388768
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1388768
The integration of biology and electronics for healthcare treatments is recognized as bioelectronics, a multidisciplinary field. Bioelectronics technologies can monitor and control the regulatory activities of the nervous system by affecting specific molecular processes in neural signaling. Bioelectronics medicine is capable of managing a wide range of diseases including inflammatory and neurodegenerative diseases, cardiovascular disease, blindness, diabetes, and paralysis. Personalized medical treatment is achieved through the use of bioelectronics devices that stimulate, regulate, or block specific electronic communication signals between the brain and bodily functions. Common bioelectronics products comprise cardiac pacemakers, which regulate heart rhythm, and robotic prostheses, which mimic human movement.
Cardiovascular diseases, such as heart arrhythmias, pose a significant global health concern, with their prevalence increasing due to factors like aging populations and unhealthy lifestyles. In the United States, cardiovascular disease (CVD) remains the leading cause of death, resulting in 928,741 fatalities in 2020. The American Heart Association reports that the total costs associated with CVD, including direct expenses and lost productivity, amounted to USD 407.3 billion between 2018 and 2019. To manage heart rhythm disorders, artificial pacemakers have become indispensable medical devices. As the number of individuals requiring pacemakers to regulate their heartbeats continues to grow, there will be a greater demand for advanced and more efficient pacemaker technologies. Pacemakers are adjustable artificial electrical pulse generators that can be either temporary or permanent. Additionally, ongoing advancements in bioelectronics, such as miniaturization, improved energy efficiency, and enhanced connectivity, are expanding the range of applications and providing opportunities for market growth. However, limited healthcare infrastructure, including restricted access to specialized medical professionals, may impede the adoption of advanced bioelectronics technologies.
The Global Bioelectronics Market is segmented on the basis of Type, product, Application, and Region.
The market is divided into two categories based on type: Bio-Electronic Devices and Bio-Electronic Medicine. Bio-Electronic Medicine dominates the market. The development of advanced medical devices and therapies for treating diverse health conditions is made possible through the integration of principles from biology and electronics, which is known as bio-electronic medicine, an emerging field.
The market is divided into four categories based on Product: Piezoelectric Biosensors, Electrochemical Biosensors, Thermal Biosensors, Optical Biosensors. Electrochemical Biosensors dominate the market. Electrochemical biosensors form an essential element within the realm of bioelectronics, assuming a pivotal function in identifying and measuring distinct biological molecules or analyses through the conversion of biochemical reactions into quantifiable electrical signals.
The market is divided into six categories based on application: Implantable Devices, Biochips, Prosthetics, Molecular Motors, Artificial organs, and others. Implantable Devices dominate the market. Bioelectronics is crucial in guaranteeing the harmonious integration of materials and components employed in these devices.
The Bioelectronics market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the nations involved in business activities. The North American region dominates the market, driven by the growing demand for home care and customized medicine, and supported by a highly advanced healthcare infrastructure. This infrastructure facilitates the development and adoption of bioelectronics devices for medical applications, including home care and customized medicine. According to Home Care Industry Overview and Statistics, the US home care services industry revenue in 2020 is estimated at USD96.9B and USD 97 Bn, respectively, with over 15 million patients and 600 million patient visits annually. Europe is the second largest market for Bioelectronics, owing to increased investment in research in semiconductors and biomedicine in the region.
In evaluating biosensor projects within the highly competitive diagnostics market, industrial stakeholders must consider various critical factors such as costs per test, regulatory requirements, quality control, instrumentation design, and test parameter selection. A more critical analysis of the need for biosensors is necessary to determine the most effective direction for developing biosensor technology and identify areas that require a more focused approach in basic research in bioelectronics. The bioelectronics market is characterized by ongoing research and development efforts, regulatory approvals, and collaborations between medical device companies, healthcare institutions, and academic researchers, all focused on developing bioelectronics solutions for a wide range of medical conditions. Due to the highly specialized and multidisciplinary nature of bioelectronics, collaboration between experts in engineering, neuroscience, and medicine is often necessary.
In February 2023, NevadaNano has successfully concluded its Series C funding round, securing USD30 million to expedite the advancement of innovative emissions-tracking technology. This substantial investment empowers to enhance production capabilities and expand the reach of their latest solution, MethaneTrack, in order to effectively address the growing need for affordable and continuous detection and measurement of methane emissions," affirms Ian Rogoff, the Chief Executive Officer of NevadaNano. MethaneTrack enables our clients to promptly assess and mitigate their methane emissions, aligning with their Environmental, Social, and Governance objectives in a financially viable manner, often yielding positive returns on investment.
The scope of this report covers the market by its major segments, which include as follows: